Literature DB >> 2966015

Augmented expression of atrial natriuretic polypeptide gene in ventricles of spontaneously hypertensive rats (SHR) and SHR-stroke prone.

H Arai1, K Nakao, Y Saito, N Morii, A Sugawara, T Yamada, H Itoh, S Shiono, M Mukoyama, H Ohkubo.   

Abstract

Tissue levels of atrial natriuretic polypeptide (ANP) and ANP messenger RNA (mRNA) in the atrium and ventricle were measured simultaneously in spontaneously hypertensive rats (SHR) and its substrain, SHR-stroke prone (SHRSP), and these levels were compared with those in control Wistar-Kyoto rats (WKY). At 27 weeks of age with established hypertension and ventricular hypertrophy, ANPmRNA levels in ventricles from SHR and SHRSP were markedly increased, and total contents of ventricular ANPmRNA in SHR and SHRSP were approximately 50% and 250%, respectively, of the corresponding atrial contents. However, levels and total contents of atrial ANPmRNA in SHR and SHRSP were similar to those of WKY, and the total content of ventricular ANPmRNA in WKY was only 6% of the content of atrial ANPmRNA. ANP concentrations in ventricles of SHR and SHRSP were increased in association with the augmentation of ANPmRNA levels. During the prehypertensive stage at 6 weeks of age, slight increases in levels and total contents of ANPmRNA and ANP in the ventricle were observed only in SHRSP. These results demonstrate that the expression of the ANP gene is markedly augmented in ventricles of SHR and SHRSP, especially of SHRSP, at the stage of established hypertension and ventricular hypertrophy, and they also suggest that these genetically hypertensive rats are one of the best animal models to investigate the biosynthesis, storage, and secretion of ventricular ANP.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2966015     DOI: 10.1161/01.res.62.5.926

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  24 in total

1.  Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload.

Authors:  T Senbonmatsu; S Ichihara; E Price; F A Gaffney; T Inagami
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

2.  Identification of a cis-acting regulatory element conferring inducibility of the atrial natriuretic factor gene in acute pressure overload.

Authors:  R von Harsdorf; J G Edwards; Y T Shen; R K Kudej; R Dietz; L A Leinwand; B Nadal-Ginard; S F Vatner
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

3.  The neuron-restrictive silencer element-neuron-restrictive silencer factor system regulates basal and endothelin 1-inducible atrial natriuretic peptide gene expression in ventricular myocytes.

Authors:  K Kuwahara; Y Saito; E Ogawa; N Takahashi; Y Nakagawa; Y Naruse; M Harada; I Hamanaka; T Izumi; Y Miyamoto; I Kishimoto; R Kawakami; M Nakanishi; N Mori; K Nakao
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

4.  Ventricular expression of atrial and brain natriuretic peptides in dilated cardiomyopathy. An immunohistocytochemical study of the endomyocardial biopsy specimens using specific monoclonal antibodies.

Authors:  K Hasegawa; H Fujiwara; K Doyama; M Mukoyama; K Nakao; T Fujiwara; H Imura; C Kawai
Journal:  Am J Pathol       Date:  1993-01       Impact factor: 4.307

5.  Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene.

Authors:  Y Ogawa; H Itoh; N Tamura; S Suga; T Yoshimasa; M Uehira; S Matsuda; S Shiono; H Nishimoto; K Nakao
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

6.  Quinapril treatment and arterial smooth muscle responses in spontaneously hypertensive rats.

Authors:  P Arvola; H Ruskoaho; H Wuorela; A Pekki; H Vapaatalo; I Pörsti
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

7.  Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide.

Authors:  M Mukoyama; K Nakao; K Hosoda; S Suga; Y Saito; Y Ogawa; G Shirakami; M Jougasaki; K Obata; H Yasue
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

8.  Molecular cloning of hamster brain and atrial natriuretic peptide cDNAs. Cardiomyopathic hamsters are useful models for brain and atrial natriuretic peptides.

Authors:  N Tamura; Y Ogawa; H Itoh; H Arai; S Suga; O Nakagawa; Y Komatsu; I Kishimoto; K Takaya; T Yoshimasa
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

9.  Hypoxia induces release of atrial natriuretic peptide in rat atrial tissue: a role for this peptide during low oxygen stress.

Authors:  M E Ljusegren; R G Andersson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-08       Impact factor: 3.000

10.  Conserved mechanism of negative gene regulation by extracellular calcium. Parathyroid hormone gene versus atrial natriuretic polypeptide gene.

Authors:  T Okazaki; K Ando; T Igarashi; E Ogata; T Fujita
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.